CHDN
- NASDAQ - LEISURE - Gaming Activities
Churchill Downs Inc
|
$231.25 |
+0.10
0.04%
|
$235.60
|
$237.83
|
-2.77% |
68,720 85.90%
|
80,000
|
Most Recent Note for CHDN - 12/8/2017 1:06:55 PM
No resistance remains due to overhead supply and it is perched near its all-time high. Reported Sep '17 earnings +108% on +4% sales revenues versus the year ago period. Prior mid-day reports cautioned - "Sub par sales revenues growth rate and its up and down annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CUTR
- NASDAQ - HEALTH SERVICES - Medical Appliances & Equipment
Cutera Inc
|
$44.45 |
+3.85
9.48%
|
$45.45
|
$47.15
|
-5.73% |
431,692 208.55%
|
207,000
|
Most Recent Note for CUTR - 12/8/2017 1:09:01 PM
Perched near its all-time high after a gap up today. Showed strong sales revenues and earnings increases in the Jun and Sep '17 quarters. Prior quarterly and annual earnings (C and A criteria) is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DOV
- NYSE - CONGLOMERATES - Conglomerates
Dover Corp
|
$98.67 |
+1.96
2.03%
|
$99.15
|
$98.60
|
0.07% |
1,019,102 97.80%
|
1,042,000
|
Most Recent Note for DOV - 12/8/2017 1:12:17 PM
Hitting a new 52-week high today. Showed strong sales revenues and earnings increases in the 3 latest quarterly comparisons through Sep'17. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EBS
- NYSE - DRUGS - Biotechnology
Emergent Biosolutions
|
$43.68 |
+1.26
2.97%
|
$43.89
|
$44.97
|
-2.87% |
369,339 87.52%
|
422,000
|
Most Recent Note for EBS - 12/8/2017 1:13:22 PM
Rebounded above its 50 DMA line with volume-driven gains leaving it again perched near its all-time high. Noted with caution in prior mid-day reports - "Reported earnings +30% on +5% sales revenues for the Sep '17 quarter, but fundamental concerns remain. Prior quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
FANH
- NASDAQ - Insurance-Brokers
Fanhua Inc Ads
|
$24.27 |
+2.05
9.23%
|
$24.61
|
$23.94
|
1.38% |
706,906 268.79%
|
263,000
|
Most Recent Note for FANH - 12/8/2017 1:14:25 PM
Stubbornly held its ground, and powering to another new 52-week high with today's 3rd consecutive volume-driven gain. Prior mid-day reports repeatedly cautioned members - "Fundamental concerns remain due to its erratic earnings and sales revenues history."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HOFT
- NASDAQ - CONSUMER DURABLES - Home Furnishings & Fixtures
Hooker Furniture Corp
|
$46.55 |
-0.15 -0.32%
|
$46.90
|
$52.75
|
-11.75% |
50,558 103.18%
|
49,000
|
Most Recent Note for HOFT - 12/8/2017 1:14:49 PM
Retreating from its all-time high, it gapped down on the prior session and violated its 50 DMA line. Reported earnings +9% on +9% sales revenues for the Oct '17 quarter, below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth history included a downturn in FY '14.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
KRO
- NYSE - CHEMICALS - Specialty Chemicals
Kronos Worldwide Inc
|
$25.19 |
-0.12 -0.47%
|
$25.94
|
$29.49
|
-14.58% |
465,362 98.18%
|
474,000
|
Most Recent Note for KRO - 12/8/2017 1:15:25 PM
Violated its 50 DMA line with a big volume-driven loss on 12/06/17. Showed strong sales revenues and earnings increase in recent quarterly comparisons. Earnings history has been erratic and not a good match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
KTEC
- NASDAQ - MANUFACTURING - Diversified Machinery
Key Technology Inc
|
$17.80 |
-0.02 -0.11%
|
$17.88
|
$19.67
|
-9.51% |
27,098 225.82%
|
12,000
|
Most Recent Note for KTEC - 12/8/2017 1:15:53 PM
Showed improved sales revenues and earnings increases in the Jun and Sep '17 quarters. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MIXT
- NYSE - Computer Sftwr-Enterprse
MiX Telematics Ltd ADS
|
$11.28 |
-0.25 -2.17%
|
$11.50
|
$11.90
|
-5.21% |
78,156 126.06%
|
62,000
|
Most Recent Note for MIXT - 12/8/2017 1:16:42 PM
This South Africa based Computer Software - Enterprise firm is perched near its 52-week high. Stubbornly held its ground and found support near its 50 DMA line since noted in the 7/24/17 mid-day report. Quarterly earnings increases through Sep '17 were above the +25% minimum guideline (C criteria). Up and down annual earnings (A criteria) history is not a good match with the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NCS
- NYSE - MATERIALS & CONSTRUCTION - General Building Materials
N C I Building Systems
|
$19.68 |
+0.63
3.28%
|
$19.80
|
$19.40
|
1.42% |
468,095 101.76%
|
460,000
|
Most Recent Note for NCS - 12/8/2017 1:17:50 PM
Powering back with above average volume to hit new 52-week highs this week. Prior mid-day reports cautioned - "Fundamental flaws are concerns. It survived but failed to impress since dropped from the Featured Stocks list on 5/01/05."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NEOG
- NASDAQ - DRUGS - Diagnostic Substances
Neogen Corp
|
$82.29 |
-0.44 -0.53%
|
$83.03
|
$85.89
|
-4.19% |
111,225 96.72%
|
115,000
|
Most Recent Note for NEOG - 12/8/2017 1:19:05 PM
Hovering near its 52-week high, and no resistance remains due to overhead supply. Prior mid-day reports cautioned - "Fundamentals are a concern due to sub par earnings increases below the +25% minimum guideline (C criteria) in prior quarterly comparisons."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NOAH
- NYSE - FINANCIAL SERVICES - Asset Management
Noah Holdings Ltd Ads
|
$42.97 |
-1.34 -3.02%
|
$44.50
|
$48.30
|
-11.04% |
372,902 119.52%
|
312,000
|
Most Recent Note for NOAH - 12/8/2017 1:19:30 PM
Pulled back from its all-time high last week, finding support above its 50 DMA line. Reported earnings +20% on +13% sales revenues for the Sep '17 quarter. Prior quarterly comparisons were below the +25% minimum earnings (C criteria) guideline. It was dropped from the Featured Stocks list on 12/10/13.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PMBC
- NASDAQ - BANKING - Regional - Pacific Banks
Pacific Mercantile Bancp
|
$8.95 |
-0.50 -5.29%
|
$9.40
|
$9.85
|
-9.14% |
15,363 109.74%
|
14,000
|
Most Recent Note for PMBC - 12/8/2017 1:21:16 PM
Slumping below its 50 DMA line. Prior quarterly and annual earnings (C and A criteria) is not a match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SCMP
- NASDAQ - Medical-Biomed/Biotech
Sucampo Pharmaceuticals
|
$16.00 |
+0.40
2.56%
|
$16.80
|
$17.70
|
-9.60% |
2,072,499 204.59%
|
1,013,000
|
Most Recent Note for SCMP - 12/8/2017 1:21:35 PM
Perched at its 52-week high today while adding to an impressive streak of volume-driven gains. Quarterly earnings have been below the +25% minimum guideline (C criteria) in the 3 past quarterly comparisons through Sep '17.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VNOM
- NASDAQ - Oil&Gas-U S Expl&Prod
Viper Energy Partners Lp
|
$22.14 |
+0.93
4.38%
|
$22.66
|
$22.30
|
-0.72% |
476,660 253.54%
|
188,000
|
Most Recent Note for VNOM - 12/8/2017 1:22:14 PM
Gapped up today hitting new multi-year highs, getting more extended from any sound base. Recent quarterly comparisons through Sep '17 showed strong sales revenues and earnings increases well above the +25% minimum guideline (C criteria). Since its $26 IPO in June 2014 it completed additional new Public Offerings in Sep '14, Jul '16, Jan '17 and Jul '17.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|